MicroRNA-874 as a tumor suppressor in maxillary sinus squamous cell carcinoma based on microRNA expression signature Abstract #4143 Toyoyuki Hanazawa 1,

Slides:



Advertisements
Similar presentations
Cancer: a genetic disease of inherited and somatic mutations n Gene mutations and/or genetic instability are involved in many cancers. n Viruses and environmental.
Advertisements

Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
Prediction of Therapeutic microRNA based on the Human Metabolic Network Ming Wu, Christina Chan Bioinformatics Advance Access Published January 7, 2014.
Molecular networks regulated by tumor suppressive microRNA-375 in head and neck squamous cell carcinoma Abstract #137 Takashi Kinoshita 1,2, Toyoyuki Hanazawa.
Gene regulation in cancer 11/14/07. Overview The hallmark of cancer is uncontrolled cell proliferation. Oncogenes code for proteins that help to regulate.
1. What is the Central Dogma? 2. How does prokaryotic DNA compare to eukaryotic DNA? 3. How is DNA organized in eukaryotic cells?
34 Cancer.
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs LEE P. LIM, NELSON C. LAU, PHILIP GARRETT-ENGELE ANDREW GRIMSON,
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
Chapter 15 Noncoding RNAs. You Must Know The role of noncoding RNAs in control of cellular functions.
Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Kevin Paiz-Ramirez.
Malignant Melanoma and CDKN2A
“Discovery Of Gene Ripple Effect Which Causes Cervical Cancer to Advance And Spread” May 19 th, 2011
Co-supervisor: Prof Richard Lock
Cancer Uncontrolled cell growth. Cellular differentiation is the process by which a less specialized cell becomes a more specialized cell type. Occurs.
Miki Fuse 1, Satoko Kojima 2, Takeshi Chiyomaru 3, Hideki Enokida 3, Kazumori Kawakami 3, Hirofumi Yoshino 3, Nijiro Nohata 1, Yukio Naya 2, Tomohiko Ichikawa.
CONTEXT SPECIFIC ROLE OF DEUBIQUITYLASE ENZYME, USP9X, IN HEAD AND NECK CANCER Devathri Nanayakkara Eskitis Institute for Drug Discovery Griffith University.
SiRNA-mediated Down-Regulation of Survivin Inhibits Bladder Cancer Cell Growth S. Fuessel, S.Ning, M. Kotzsch #, K. Kraemer, M. Kappler*, U. Schmidt, H.
Huidi Liu, M.D. & Ph.D Genomics Research Centre Harbin Medical University, China Reduced expression of SOX7 in ovarian cancer: a novel.
Background and Aims of study Take home notes miR-1 and miR-133a expression were down-regulated in tumor tissues and their expression were positively correlated.
MicroRNA implication in urinary bladder cancer A. Zaravinos 1, J. Radojicic 3, G.I. Lambrou 2, D. Volanis 1,4, D. Delakas 4, E.N. Stathopoulos 3, D.A.
吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008
Marco Magistri , Journal Club. A non-coding RNA (ncRNA) is any RNA molecule that is not translated into a protein “Structural genes encode proteins.
Apostolos Zaravinos and Constantinos C Deltas Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological.
OncomiR and tumor-suppressor miR expression in triple-negative primary breast cancer. Jelena Radojicic 1, Apostolos Zaravinos 2, Thomas Vrekoussis 1, Maria.
BRG-1 in Cancer BRG-1 is an ATPase subunit of the SWI/SNF class of chromatin remodeling complexes It has been found mutated in a number of cancer cell.
Therapeutic miRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model Janaiah Kota,1 Raghu R. Chivukula,2 Kathryn A. O’Donnell,3,4 Erik A.
Chapter 18 Regulation of Gene Expression Dr. Joseph Silver.
OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best.
Cancer Detection and Diagnosis Early Cancer May Not Have Any symptoms Pap Test Mammograms Blood tests Prostate-specific antigen (PSA) Carcinoembryonic.
Introduction Results Conclusions Acknowledgements Alzheimer’s Disease (AD) is the most common chronic degenerative neurological disease, and there are.
Lecture 28 Genetics of Cancer Copyright © 2010 Pearson Education Inc.
Cancer Accelerated Biology. Learning Objectives The different methods of diagnosing cancer. The difference between a malignant tumor and a benign tumor.
CBioPortal Web resource for exploring, visualizing, and analyzing multidimentional cancer genomics data.
-33 Red bar: tonsil tumour samples, n =14 x2 Green bar: tonsil normal samples, n = 9 x2 A B Supplementary Figure 1. A)Unsupervised HCL analysis was used.
Expression profile of oncomiRs and tumor-suppressor miRs in urothelial carcinoma of the bladder Apostolos Zaravinos 1, George I. Lambrou 2, Jelena Radojicic.
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
1. 2 Sylvia S. Mader Concepts of Biology © Zanichelli editore, 2012 Sylvia S. Mader Immagini e concetti della biologia.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Novel Integrative Methods for Gene Discovery Associated.
Supplementary Figure 1 Supplementary Figure 1. Representative micrographs of migration and invasion assays. miR-452 or si-WWP1 transfectants inhibited.
Gene Expression (Epigenetics) Chapter 19. What you need to know The functions of the three parts of an operon. The role of repressor genes in operons.
1. What is the Central Dogma? 2. How does prokaryotic DNA compare to eukaryotic DNA? 3. How is DNA organized in eukaryotic cells?
EUKARYOTIC CELL SIGNALING VII Abnormal Signaling in Cancer Signaling to p53 Dr. Ke Shuai Office: 9-240M Factor Tel: X69168
Date of download: 6/23/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. A model depicting the modes of action of genotoxic and nongenotoxic.
Mestrado Integrado em Medicina Biologia Celular e Molecular II
Yuna Jo. Introduction Prostate cancer (PCa) continues to burden the Western world with its high rates of incidence and mortality despite the.
miRNA-targets cross-talks: key players in glioblastoma multiforme
Molecular Genetics: Part 2B Regulation of metabolic pathways:
GENETIC BIOMARKERS.
MicroRNA-34a: a key regulator in the hallmarks of renal cell carcinoma
Fig. 1 Increased MIR155HG expression correlates with glioma grade and mesenchymal transition and confers a poor prognosis in GBM patients. (A) The level.
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
Cell Physiol Biochem 2017;44:1867– DOI: /
Regulation of Gene Expression
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
MicroRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7  Yixiong Lin, Jianjun Liu, Yuqi Huang,
Regulation of Gene Expression
Altered microRNA expression in stenoses of native arteriovenous fistulas in hemodialysis patients  Lei Lv, MD, Weibin Huang, MD, Jiwei Zhang, MD, Yaxue.
UHRF1 is regulated by miR-9 in colorectal cancer
BIOLOGY 12 Cancer.
Transcription Initiation:
Transcription Initiation:
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Loyola Marymount University
Long Noncoding RNAs and Hepatocellular Carcinoma
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
Presentation transcript:

microRNA-874 as a tumor suppressor in maxillary sinus squamous cell carcinoma based on microRNA expression signature Abstract #4143 Toyoyuki Hanazawa 1, Nijiro Nohata 1,2, Takashi Kinoshita 1,2,Naoko Kikkawa 1,Miki Fuse 1, Takeshi Chiyomaru 3, Hirofumi Yoshinoi 3, Hideki Enokida 3, Masayuki Nakagawa 3, Yoshitaka Okamoto 1 and Naohiko Seki 2 1 Department of Otorhinolaryngology / Head and Neck Surgery, Graduate School of Medicine, Chiba University, Chiba Japan 2 Department of Functional Genomics, Graduate School of Medicine, Chiba University, Chiba, Japan 3 Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan MicroRNAs (miRNAs) are an abundant class of small non-protein-coding RNAs that function as negative gene regulators. They regulate diverse biological processes, and bioinformatic data indicates that each miRNA can control hundreds of gene targets, underscoring the potential influence of miRNAs on almost every genetic pathway. Recent evidence has shown that miRNA mutations or mis-expression correlate with various human cancers and indicates that miRNAs can function as tumour suppressors and oncogenes. Overexpressed miRNAs can act as oncogenes by repressing tumor suppressor genes, whereas under-expressed miRNAs can function as tumor suppressors by negatively regulating oncogenes. miRNAs have been clearly shown to repress the expression of important cancer-related genes and might prove useful in the diagnosis and treatment of cancer. Role of microRNAs in human cancers Maxillary sinus squamous cell carcinoma (MSSCC) comprises 2-3% of all cancers of head and neck tumor and the annual incidence rate is per 100,000 populations. Clinical symptoms of MSSCC present insidiously. Primary tumors are often diagnosed as advanced disease. The 5-years survival rate of T4 tumors is 50% around. Local recurrence is the most common cause of treatment failure and death. Maxillary sinus squamous cell carcinoma Aims of this study 1.To identify the down-regulated miRNAs based on miRNA expression signature using clinical specimens of maxillary sinus squamous cell carcinoma. 2.To elucidate the functional significance of microRNA-874 (miR-874) in maxillary sinus squamous cell carcinoma. 3.To find candidate target genes of tumor suppressive miR-874 by performing genome- wide analysis (microarray analysis and web-based program search). Take home notes 1.We revealed that miR-874 was down-regulated in tumor tissues and functioned as a tumor suppressor based on miRNA expression signature of clinical specimens of maxillary sinus squamous cell carcinoma. 2.Genome-wide expression analysis using miR-874 transfectants revealed that PPP1CA, PAAF1 and TGOLN2 were overexpressed in tumor tissues and were inversely correlated with miR-874 expression in clinical samples. 3. miR-874 directly regulated PPP1CA expression in both mRNA and protein levels. 4.Knockdown of PPP1CA by siRNA inhibited cell proliferation in IMC-3 cells. 5.The PP1a catalytic subunit can form complexes with many regulatory subunits, which regulate various cellular activities such as cell cycle, apoptosis, and signal transduction. 1. Characteristics of twenty patients with maxillary sinus squamous cell carcinoma miRNA Accession No.Chromosome Locus Fold change Normalized ratio P-Value NormalTumor miR-874MIMAT q E E miR-133aMIMAT q11.2, 20q E E miR-375MIMAT q E E miR-204MIMAT q E E miR-1MIMAT q11.2, 20q E E No.AgeGenderDifferentiationTNMStage 168MaleWell4b00IVB 277MalePoor300III 376MaleModerate300III 461MaleWell300III 554MalePoor300III 665FemalePoor4b00IVB 765MaleModerate4a00IVA 864MalePoor4b00IVB 974MaleWell4a00IVA 1071MaleModerate310III 2. Top five down-regulated miRNAs from TaqMan Low Density Array (n=5) 3. miR-874 expression levels and tumor suppressive function in IMC-3 cells AACR 103 rd ANNUAL MEETING, Tuesday April 3, 2012, 1:00 PM – 5:00 PM NormalTumor P = miR-874 expression (Normalized to RNU48 ) *:P< 0.05 No.AgeGenderDifferentiationTNMStage 1164MaleModerate4a00IVA 1280MaleModerate4a00IVA 1366FemalePoor4a2c0IVA 1467MaleModerate4a00IVA 1560MalePoor4a00IVA 1666FemaleModerate4a00IVA 1785MalePoor4a00IVA 1869MaleWell4a00IVA 1957MalePoor4a00IVA 2069MalePoor4a2b0IVA controlmiR-874 Proliferation (% of control) * EntrezGene ID GeneNameGene Symbol Log2 rario miR-874 target 1373carbamoyl-phosphate synthetase 1, mitochondrial CPS lactate dehydrogenase ALDHA eukaryotic translation elongation factor 1 alpha 1 EEF1A protein phosphatase 1, catalytic subunit, alpha isozyme PPP1CA prosaposinPSAP proteasomal ATPase- associated factor 1 PAAF beta-2-microglobulinB2M annexin A2 pseudogene 1ANXA2P phosphoglycerate mutase 1 (brain) PGAM collagen, type XII, alpha 1COL12A insulin-like growth factor binding protein 3 IGFBP GNAS complex locusGNAS cell division cycle associated 7-like CDCA7L eukaryotic translation initiation factor 3, subunit H EIF3H melanoma antigen family D, 2MAGED trans-golgi network protein 2 TGOLN neighbor of BRCA1 gene 1NBR heat shock protein 90kDa beta (Grp94), member 3 (pseudogene) HSP90B3P- Overexpressed miRNAs as oncogenes Underexpressed miRNAs as tumor suppressors rs= P=0.002 rs= P=0.002 rs= P= P= NormalTumor Normalized to GUSB PPP1CA mRNA expression P= NormalTumor PAAF1 mRNA expression Normalized to GUSB P= NormalTumor TGOLN2 mRNA expression Normalized to GUSB 4. Down-regulated genes by miR-874 in IMC-3 cells 5. Three candidate genes were overexpressed in tumor and were inversely correlated with miR-874 expression PPP1CA mRNA expression (% of miR-control) 0 20 * PP1α normalized to β-Actin PP1α β-Actin 0 si-control si-PPP1CA_1 si-PPP1CA_2 Cell viability (% of si-control) 20 *** *** (%) hr24hr48hr72hr Cell number (x10 4 ) miR-874 miR-control * ‘...GCCGAGGCUGCAGCUCAGGGCAA... ||||||| 3’ AGCCAGGGAGCCCGGUCCCGUC 5‘...GCCGAGGCUGCAGCU A... ||||||| 3’ AGCCAGGGAGCCCGGUCCCGUC Position deletion Position PPP1CA (NM_ ) 3’UTR length:353 miR-874 target sites miR-control miR-874 *:P< 0.05 Luminescence (normalized) wild type * deletion *:P< 0.05 * hr24hr48hr72hr Cell number (x10 4 ) si-PPP1CA_1 si-control si-PPP1CA_2 * *:P<0.0018, **:P< ***:P< miR-874 directly regulated PPP1CA expression in both mRNA and protein levels 7. si-PPP1CA inhibited cell growth in IMC-3 cells